文献速递神经技术与安全MR

在小鼠模型中用19F MRI评估针对胶质瘤的嵌合抗原受体T细胞治疗的氧测定反应

Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model.
PubMed 文献 · Radiol Imaging Cancer · 2021-01-22

研究在小鼠免疫治疗模型中,用全氟化碳纳米乳滴传感器标记人胶质母细胞瘤细胞或人T细胞,通过19F自旋晶格弛豫时间测量肿瘤内两种细胞的胞内氧分压。结果显示CAR T细胞输注后3天肿瘤细胞出现延迟、短暂的高氧,伴随显著肿瘤细胞杀伤和CAR T细胞浸润,而CAR或未转导T细胞胞内氧分压随时间无显著变化。

要点

  • CAR T细胞输注后3天肿瘤细胞胞内氧分压出现延迟、短暂高氧。
  • 该高氧与生物发光成像和组织学所见的肿瘤细胞杀伤及CAR T细胞浸润一致。
  • CAR或未转导T细胞胞内氧分压随时间无显著变化。

关键影像表现/征象

  • CAR T细胞输注后3天肿瘤细胞胞内氧分压出现延迟、短暂的高氧。
  • 该高氧与生物发光成像和组织学所见的显著肿瘤细胞杀伤及CAR T细胞浸润一致。
  • 使用同样方法,CAR或未转导T细胞胞内氧分压随时间未检测到显著变化。
  • 治疗时总19F肿瘤细胞信号淬灭,与探针从凋亡肿瘤细胞中快速组织清除一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the cell-specific, intracellular partial pressure of oxygen (Po2) dynamics of both tumor and chimeric antigen receptor (CAR) T cells in a murine immunotherapy model.

MATERIALS AND METHODS: Human glioblastoma cells or human T cells were intracellularly labeled with perfluorocarbon nanoemulsion droplet sensors prior to in vivo injection in severe combined immunodeficient mice to measure Po2 in the two cell types in response to treatment. Two main sets of experiments were performed: (a) mice were injected in the flank with perfluorocarbon-labeled human glioblastoma cells and were then inoculated with either CAR T cells or untransduced T cells or were untreated 5 days after tumor inoculation; and (b) mice with unlabeled glioblastoma tumors were inoculated with perfluorocarbon-labeled CAR T cells or untransduced T cells 5 days after tumor inoculation. Longitudinal fluorine 19 (19F) spin-lattice relaxation time measurements of the tumor mass were used to ascertain absolute Po2 in vivo. Results were analyzed for significance using an analysis of variance, a linear mixed-effect model, and a Pearson correlation coefficient test, as appropriate.

RESULTS: The intracellular tumor cell Po2 temporal dynamics exhibited delayed, transient hyperoxia at 3 days after infusion of CAR T cells, commensurate with significant tumor cell killing and CAR T-cell infiltration, as observed by bioluminescence imaging and histologic findings. Conversely, no significant changes were detected in CAR or untransduced T-cell intracellular Po2 over time in tumor using these same methods. Moreover, it was observed that the total 19F tumor cell signal quenches with treatment, consistent with rapid tissue clearance of probe from apoptotic tumor cells.

CONCLUSION: Cell-specific Po2 measurements using perfluorocarbon probes can provide insights into effector cell function and tumor response in cellular immunotherapeutic cancer models.Keywords: Animal Studies, MR-Imaging, MR-Spectroscopy, Molecular Imaging-Cancer, Molecular Imaging-Immunotherapy Supplemental material is available for this article. © RSNA, 2021See also commentary by Bulte in this issue.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Chapelin F, Leach BI, Chen R, et al. Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model. Radiol Imaging Cancer. 2021. PMID: 33575659. doi:10.1148/rycan.2021200062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。